Item 1.01 | Entry into a Material Definitive Agreement. |
On November 10, 2023, Holly Energy Partners, L.P., a Delaware limited partnership (“HEP”), and Holly Energy Finance Corp., a Delaware corporation (“Finance Corp.” and, together with HEP, the “HEP Issuers”), entered into (i) a Second Supplemental Indenture (the “2027 Notes Second Supplemental Indenture”) among the HEP Issuers, as issuers, the other subsidiary guarantors party thereto (the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), to that certain Indenture, dated as of April 8, 2022, among the HEP Issuers, as issuers, the Guarantors and the Trustee, as trustee (as supplemented by the First Supplemental Indenture, dated May 22, 2022, the “Existing 2027 Notes Indenture” and, as further supplemented by the 2027 Notes Second Supplemental Indenture, the “2027 Notes Indenture”), relating to the HEP Issuers’ 6.375% Senior Notes due 2027 (the “2027 Notes”) and (ii) a Third Supplemental Indenture (the “2028 Notes Third Supplemental Indenture”) among the HEP Issuers, as issuers, the Guarantors and the Trustee, as trustee, to that certain Indenture, dated as of February 4, 2020, among the HEP Issuers, as issuers, the Guarantors and the Trustee (as successor to U.S. Bank, National Association), as trustee (as supplemented by the First Supplemental Indenture, dated March 14, 2022 and as further supplemented by the Second Supplemental Indenture, dated May 22, 2022, the “Existing 2028 Notes Indenture” and, as further supplemented by the 2028 Notes Third Supplemental Indenture, the “2028 Notes Indenture” and, together with the 2027 Notes Indenture, the “HEP Indentures”), relating to the HEP Issuers’ 5.000% Senior Notes due 2028 (the “2028 Notes” and, together with the 2027 Notes, the “HEP Notes”).
Each of the 2027 Notes Second Supplemental Indenture and the 2028 Notes Third Supplemental Indenture was entered into to effectuate the amendments (the “Proposed Amendments”) to the Existing 2027 Notes Indenture and the Existing 2028 Notes Indenture, respectively, for which consents were solicited in the previously announced private exchange offers (the “Exchange Offers”) and consent solicitations (the “Consent Solicitations”) by HF Sinclair Corporation, a Delaware corporation (“HF Sinclair”), with respect to the HEP Notes. As of 11:00 a.m., New York City time, on November 10, 2023, HF Sinclair, on behalf of the HEP Issuers, had received valid consents from at least a majority of the outstanding aggregate principal amount of each series of the HEP Notes, which amounts were sufficient to constitute the requisite consents to approve the Proposed Amendments. Following execution of the 2027 Notes Second Supplemental Indenture and the 2028 Notes Third Supplemental Indenture, the consents received were not able to be revoked.
Each of the 2027 Notes Second Supplemental Indenture and the 2028 Notes Third Supplemental Indenture amends the 2027 Notes Indenture and the 2028 Notes Indenture, respectively, to, among other things, eliminate from each HEP Indenture, as it relates to each series of HEP Notes (i) substantially all of the restrictive covenants, (ii) certain of the events which may lead to an “Event of Default”, (iii) the U.S. Securities and Exchange Commission (the “SEC”) reporting covenant and (iv) the requirement of HEP to offer to purchase the HEP Notes upon a change of control. Each of the 2027 Notes Second Supplemental Indenture and the 2028 Notes Third Supplemental Indenture was effective upon execution but will only become operative upon the settlement date of the applicable Exchange Offer, which is expected to be on or about the third business day following expiration of the Exchange Offers (the “Settlement Date”), such expiration date being 5:00 p.m., New York City time, on November 29, 2023, unless extended or earlier terminated (such date and time, as they may be extended or terminated, the “Expiration Date”). The Settlement Date is expected to be on or about December 4, 2023, unless HF Sinclair extends the Expiration Date or terminates the Exchange Offers.
The foregoing descriptions of the 2027 Notes Second Supplemental Indenture and the 2028 Notes Third Supplemental Indenture do not purport to be complete and are qualified in their entirety by reference to the 2027 Notes Second Supplemental Indenture and 2028 Notes Third Supplemental Indenture, copies of which are filed as Exhibits 4.1 and 4.2, respectively, to this Current Report on Form 8-K and incorporated into this Item 1.01 by reference.
The Exchange Offers and Consent Solicitations are being made solely pursuant to the terms and subject to the conditions set forth in the confidential exchange offer memorandum and consent solicitation statement, dated as of October 30, 2023 (the “Exchange Offer Memorandum”), in a private offering exempt from, or not subject to, registration under the Securities Act of 1933, as amended (the “Securities Act”), and are subject to certain conditions set forth in the Exchange Offer Memorandum, although HF Sinclair may generally waive any such conditions at any time. Notwithstanding the foregoing, HF Sinclair may not waive or modify the condition that the merger of a wholly-owned subsidiary of HF Sinclair with and into HEP, with HEP surviving as an indirect, wholly-owned subsidiary of HF Sinclair (the “Proposed Merger”) shall have been consummated.
2